Evening primrose oil (EPO) is extracted from the seeds of Oenothera biennis and is one of the richest plant sources of gamma-linolenic acid (GLA)—an omega-6 fatty acid with distinct anti-inflammatory properties. Despite the omega-6 label, GLA behaves very differently from the pro-inflammatory omega-6 linoleic acid that dominates most Western diets.
GLA vs. Standard Omega-6: A Key Distinction
Most omega-6 fatty acids (particularly arachidonic acid derived from linoleic acid) drive inflammatory prostaglandins (PGE2, PGF2α) that worsen cramping, bloating, and inflammation. GLA takes a different metabolic path—it's converted primarily to dihomo-gamma-linolenic acid (DGLA), which produces prostaglandin E1 (PGE1), an anti-inflammatory eicosanoid.
PGE1 has several relevant effects:
- Inhibits platelet aggregation
- Reduces inflammation
- Dilates blood vessels
- Modulates the immune response in atopic conditions
This is why EPO can't be lumped with standard pro-inflammatory omega-6 supplementation—it's functionally closer to an anti-inflammatory agent.
PMS Evidence: What the Research Shows
EPO for PMS is one of its most studied applications. The evidence is mixed but leans supportive, particularly for specific symptoms.
Breast tenderness (mastalgia): The strongest evidence. Multiple RCTs and clinical trials support EPO reducing cyclical breast pain. A 1981 double-blind trial in the Lancet found EPO significantly more effective than placebo for mastalgia. The proposed mechanism is PGE1-mediated reduction in breast tissue sensitivity to circulating hormones.
General PMS symptoms: Results are more variable. Some trials show significant reductions in mood symptoms, irritability, and fluid retention; others show only modest effects. A 2010 meta-analysis in the Journal of Reproductive Medicine found that GLA-containing EPO reduced PMS severity scores compared to placebo, though effect sizes were modest.
Dose for PMS: Typically 1-3g per day, taken throughout the cycle or specifically during the luteal phase (day 14 onward). Starting with 1g and titrating to 3g is a reasonable approach. The GLA content varies by product—look for EPO standardized to at least 8-10% GLA.
Timing: Some practitioners suggest taking EPO only during the luteal phase to target PMS specifically. Clinical trials have used both continuous and luteal-phase-only protocols—there's no clear consensus on which is superior.
Skin Conditions: Atopic Dermatitis and Dry Skin
GLA plays a significant role in skin barrier function. People with atopic dermatitis (eczema) often have impaired conversion of linoleic acid to GLA due to reduced delta-6-desaturase enzyme activity—meaning they can't make enough GLA even with adequate dietary omega-6.
Atopic dermatitis: Multiple RCTs support EPO for reducing eczema severity, itch, and skin barrier impairment. A Cochrane review acknowledged the evidence was mixed but noted trials showing significant improvement in SCORAD (severity scoring for atopic dermatitis) index. More recent trials using higher doses (4-6g/day) tend to show stronger effects.
General dry skin: Supplemental GLA improves skin hydration, reduces transepidermal water loss, and improves elasticity in non-eczematous dry skin. A 2005 RCT in the British Journal of Nutrition found that 3g/day GLA from borage oil significantly improved dry skin parameters.
Oral vs. topical EPO: Both show benefit for skin. Oral supplementation addresses systemic GLA levels, while topical application delivers GLA directly to the skin barrier. For atopic dermatitis specifically, oral supplementation appears to have systemic anti-inflammatory effects beyond what topical application achieves.
Bone Health
An underappreciated benefit: GLA may support bone density, particularly in postmenopausal women. A 3-year RCT published in Calcified Tissue International found that women supplementing with EPO plus fish oil maintained bone density significantly better than placebo, while the placebo group lost bone at the lumbar spine. The mechanism likely involves GLA's effect on prostaglandins that regulate osteoclast activity.
This makes EPO particularly interesting as part of a bone health stack in perimenopausal and postmenopausal women.
Hot Flashes: Mixed Evidence
EPO is frequently marketed for hot flash relief, but the evidence here is the weakest of its applications. Two RCTs—including a 2013 Iranian trial in Archives of Gynecology and Obstetrics—found EPO significantly reduced hot flash frequency and severity compared to placebo. However, other trials have found no significant effect.
Current assessment: EPO may help some women with hot flashes, particularly for intensity rather than frequency. It's worth a 2-3 month trial if other first-line approaches (black cohosh, lifestyle) haven't provided sufficient relief, but it shouldn't be the primary recommendation for this indication.
Dosage, Forms, and Timing
Standard PMS/hormonal dose: 1-3g per day Skin conditions: 3-6g per day (higher end supported by eczema trials) Bone support: 3g EPO + fish oil combination
Form: Liquid softgels are most common; look for products standardized to GLA content rather than just EPO weight. Refrigerate after opening to prevent oxidation. Take with meals to improve absorption—GLA is a fatty acid and needs some dietary fat for optimal uptake.
Timeline: Like most fatty acid supplements, EPO takes 6-12 weeks to meaningfully alter cellular fatty acid composition. Don't assess efficacy before 8-12 weeks of consistent use.
Safety and Interactions
EPO is generally well tolerated. Mild side effects include nausea, soft stools, and headache—usually at higher doses.
Interactions to note:
- Anticoagulants (warfarin, aspirin): GLA has antiplatelet effects. Use cautiously and disclose to prescribers.
- Phenothiazines (antipsychotic medications): Case reports of seizures with combined use in epilepsy-prone individuals. Use with caution.
Pregnancy: Avoid in first and second trimester. EPO was historically used to ripen the cervix in late pregnancy, but this practice is not evidence-based and potentially harmful—avoid unless specifically directed by a healthcare provider.
The Bottom Line
Evening primrose oil's GLA content gives it a meaningful anti-inflammatory mechanism distinct from standard omega-6 supplementation. The strongest evidence is for cyclical breast tenderness and atopic dermatitis. PMS evidence is supportive but variable, and hot flash evidence is mixed. Use 1-3g/day for hormonal symptoms and 3-6g/day for skin conditions, taken with food, allowing 8-12 weeks for full effect.
Track your supplements. Use Optimize free.
Related Articles
Related Supplement Interactions
Learn how these supplements interact with each other
Related Articles
More evidence-based reading
Akkermansia Muciniphila: The Gut Bacteria That Affects Metabolism and Weight
Akkermansia muciniphila is a keystone gut bacterium whose abundance strongly predicts metabolic health, gut barrier integrity, and response to weight loss interventions — and it can be deliberately cultivated.
8 min read →Resistant Starch for Gut Health: The Prebiotic That Changes Body Composition
Resistant starch is one of the few dietary compounds with simultaneous evidence for improving gut microbiome diversity, reducing postprandial glucose, and improving body composition — through mechanisms that are now well understood.
9 min read →Butyrate Supplements: What This Short-Chain Fatty Acid Does for Your Gut
Butyrate is the primary fuel source for colon cells and a critical regulator of gut barrier function, inflammation, and even gene expression — but supplementing it effectively is more complicated than it appears.
8 min read →